R-Biopharm AG: Flu tests from R-Biopharm also detect new virus variants
25.11.2022 11:23:27 CET | news aktuell GmbH | Press release
Darmstadt, November 25, 2022: The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany.
"Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. " Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations."
This means laboratories can continue to reliably confirm or rule out influenza infections using R-Biopharm's RIDA®GENE (PG0505, PG0545, PG6825) assays. The tests are multiplex real-time RT-PCR for the direct qualitative detection of influenza viruses.
About R-Biopharm
R-Biopharm AG, located in Darmstadt, is one of Germany's leading biotechnology companies. Founded in 1988, the company is family-run in the second generation and considers itself as a pioneer for health and quality of life. Its aspiration: to provide the highest possible precision, safety, clarity and certainty in prevention, therapy and healing. To this end, R-Biopharm develops technologies, products and solutions for Clinical Diagnostics, Nutrition Care and Food and Feed Analytics – and does so in internationally recognized top quality. R-Biopharm is the world market leader for test systems in the field of allergen analysis.
R-Biopharm unites research, development and sales under one roof in order to respond to ever new challenges with agile processes and to accompany the steadily growing world population into a new health era. The company is represented in more than 120 countries – through 29 subsidiaries and 120 distributors. It employs around 1,400 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the "Sustainability Award" for sustainable and profitable growth.
Press contact:
Simone Feiler
Head of Corporate Brand Communication
https://r-biopharm.com/de/kontakt/presse
https://r-biopharm.com/de/news-presse/download-galerie
R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt
Phone: 0 61 51 - 81 02-538
Mobile: 0 160 - 55 273 60
Fax: 0 61 51 - 81 02-40
Email: s.feiler@r-biopharm.de
Images
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
The strength of direct sales and a global community / Vorwerk increases 2025 revenue to a record EUR 3.6 billion21.5.2026 13:50:20 CEST | Press release
The Vorwerk Group closed the 2025 financial year with a new record revenue of EUR 3.6 billion despite a challenging market environment. Compared to the previous year, this corresponds to growth of 14.1 percent. The operating result also developed positively at EUR 278 million and was significantly above the previous year’s level (+28.2 percent). At the same time, the financial year marked the first year of implementation of Strategy 2030. The 2025 financial year marked the first year of implementation of Strategy 2030. The success confirms the strategic direction of the Vorwerk Group and once again underlines the strength of the Vorwerk direct sales model and the global Vorwerk community. The akf Bank, the Group’s third-largest business unit with revenue of EUR 673 million, will become even more visible as part of the Group going forward, with a new brand identity and a clear affiliation with Vorwerk.
Clean Energy Meets Wild Nature: PLAN-B NET ZERO Becomes Official Rewilding Partner of Planet Wild21.5.2026 08:48:54 CEST | Press release
(Berlin, Germany) – PLAN-B NET ZERO, the Swiss GreenTech scale-up and pioneer of the Neo Energy category, is entering a strategic partnership with Planet Wild – the Berlin-based rewilding organisation that has been redefining the global restoration movement since its founding in 2022. As the first official B2B Rewilding Partner, PLAN-B NET ZERO will support ongoing and upcoming missions to restore natural ecosystems around the world. Intact ecosystems are the foundation of a stable climate, functioning biodiversity, and liveable habitats for the long term. Yet natural habitats are under pressure worldwide: forests are disappearing, species are being lost, and entire ecosystems are falling out of balance. Rewilding addresses this directly – with the goal of restoring natural processes and giving nature the space to regenerate itself. The partnership brings together two approaches that fall short on their own: clean energy and intact nature. Because a stable climate needs both: a decarbo
European digital sovereignty: Infomaniak's founder transfers control of his company to a foundation20.5.2026 09:55:59 CEST | Press release
Geneva, 20 May 2026 — On May 13th, 2026, Boris Siegenthaler, Infomaniak's founder, transferred the majority of Infomaniak's voting rights to a new Swiss public-interest foundation. An irrevocable move, rare in Europe, that places one of the pioneers of the European Web beyond the reach of any takeover.
World’s first clearing bank for the AI era: Augustus receives conditional full service bank charter from the OCC12.5.2026 10:00:00 CEST | Press release
New York - Augustus, formerly known as Ivy, has received conditional approval from the Office of the Comptroller of the Currency (OCC), the US federal banking regulator, to establish Augustus Bank, N.A. as a full service US national bank. Augustus Bank N.A. will be the world’s first clearing bank for the AI era, built on a stablecoin and AI-native core – a bank that’s always open, made for machines, at the speed of compute.
Innomotics accelerates LNG electrification with major eLNG drive orders worldwide11.5.2026 13:37:15 CEST | Press release
Innomotics wins several orders to provide motor and drive technology for eLNG projects, totaling a volume in the higher double-digit million EUR range Innomotics advances electrification of LNG production with eLNG solutions based on electric drive systems Significant operational, environmental, and financial benefits compared to conventional turbine-based LNG plants Enables decarbonization and supports global transition to sustainable energy systems
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom